pre-IPO PHARMA
COMPANIES VC JOBS NEWS CONTACT

aro-biotherapeutics PRESS RELEASE ARCHIVE

Sep 15, 2022

Aro Biotherapeutics Receives FDA Rare Pediatric Drug Designation for ABX1100 for the Treatment of Pompe Disease

Aug 10, 2022

Aro Biotherapeutics Receives FDA Orphan Drug Designation for ABX1100 for the Treatment of Pompe Disease

May 11, 2022

Aro Biotherapeutics to Present New Preclinical Data Highlighting the Potential of Centyrin-siRNA Conjugates for the Treatment of Pompe Disease

Mar 30, 2022

Aro Biotherapeutics to Highlight Therapeutic Potential of Centyrin Oligonucleotide Conjugates at Upcoming Industry Conferences

Jan 12, 2022

Aro Biotherapeutics Expands Leadership Team with Appointment of Sukumar Sakamuri, Ph.D. as Chief Technology Officer

Oct 7, 2021

Aro Biotherapeutics Appoints Mittie Doyle, MD, FACR as Chief Medical Officer

Aug 4, 2021

Aro Biotherapeutics Expands Leadership Team and Plans Move to New Philadelphia Headquarters to Drive Next Phase of Growth

Feb 23, 2021

Aro Biotherapeutics Expands Leadership Team with Addition of Proven Scientific Executives

Jan 5, 2021

Aro Biotherapeutics Announces $88 Million Series A Financing to Advance Development of Centyrin-Targeted Genetic Medicines

Oct 13, 2020

Aro Biotherapeutics Appoints Biotechnology Executive Dr. Christopher Mirabelli to its Board of Directors and Nucleic Acid Therapeutics Expert Dr. Masad Damha to its Scientific Advisory Board

Feb 11, 2020

Aro Biotherapeutics Appoints Leading Cancer Biologist Dr. Martin McMahon and Protein Structure and Design Expert Dr. Ronald Swanson to its Scientific Advisory Board

Jan 9, 2020

Aro Biotherapeutics and Ionis Enter Licensing and Collaboration Agreement Focused on Cell-Specific Delivery of Antisense Oligonucleotides

Dec 10, 2019

Aro Biotherapeutics Names Seasoned Biopharma Industry Veteran Scott Greenberg as Vice President, Business Development and Alliance Management

Oct 15, 2019

Aro Biotherapeutics Debuts Lead Centyrin Candidate at 2019 OTS Meeting

May 1, 2019

Aro Biotherapeutics Appoints Anthony Tolcher, MD, to Scientific Advisory Board

Apr 2, 2019

Aro Biotherapeutics to Present Data on Lead Program, ABX900, at AACR

Dec 11, 2018

Aro Biotherapeutics Raises $13 Million and Establishes Leadership Team to Develop Next Generation of Protein Therapeutics

Jul 23, 2018

Isogenica Licenses CIS Display Technology to Aro Biotherapeutics for Centyrin-based Biopharmaceutical Development

Google Analytics Alternative